← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
DOW GEOFFREY S
Chief Executive Officer | President
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001977231
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 5
- Average purchase
- $25.2K
- Median purchase
- $10.1K
- Gross purchase value
- $126.1K
Companies: 60 DEGREES PHARMACEUTICALS, INC.
5 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-06-15 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Chief Executive Officer | President | $10.1K | Open filing |
| 2025-12-16 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Chief Executive Officer | President | $7.7K | Open filing |
| 2025-12-12 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Chief Executive Officer | President | $12.2K | Open filing |
| 2024-12-09 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Chief Executive Officer | President | $89.7K | Open filing |
| 2024-11-21 | 60 DEGREES PHARMACEUTICALS, INC. | SXTP | Chief Executive Officer | President | $6.4K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 1/4
- Large purchase ≥ $100k
- 0/5
- Cluster buying · 15D
- 0/5
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.